Navigation Links
Vyta Corp Acquires 100% Ownership of BIOAGRA, LLC
Date:11/5/2008

DENVER, Nov. 5 /PRNewswire-FirstCall/ -- Vyta Corp (OTC Bulletin Board: VYTC) today announced that it has reached a favorable settlement in its foreclosure litigation against BIOAGRA, LLC. Pursuant to the terms of the amicable agreement, Vyta Corp now controls 100% ownership interest in BIOAGRA, LLC, and Paul H. Metzinger, President and CEO of Vyta Corp, becomes the sole Manager, and only executive officer of BIOAGRA, LLC. Terms of the agreement are included in a Form 8-K filed today with the Securities and Exchange Commission, and can be viewed on its website at (http://www.sec.gov).

BIOAGRA, LLC manufactures, markets and distributes AGRASTIM(R), a proprietary all-natural, biologically active yeast Beta-1,3/1,6-D-glucan feed supplement. AGRASTIM(R) has been listed by The Organic Materials Review Institute (OMRI) as approved for use in organic production.

About Vyta Corp

Vyta Corp, based in Denver, Colorado, is traded on the over-the-counter NASDAQ stock market (OTCBB: VYTC) as well as on the Frankfurt, Hamburg, XETRA and Munich Exchanges (OTC: VYTA).

In addition to its 100% ownership of BIOAGRA, LLC, Vyta Corp owns various patents and intellectual properties related to NCS(R) (NanoPierce Connection System) an advanced electronic connection system. For more information on Vyta Corp, please visit its website at http://www.vytacorp.com .

About BIOAGRA, LLC

BIOAGRA, LLC is based in Hinesville, Georgia, where it produces, markets and sells AGRASTIM(R), a purified, all natural, nontoxic yeast Beta 1,3/1,6-D glucan product with a high bioactivity function that improves the immune systems of animals and humans. AGRASTIM(R) is also used to replace growth promotion antibiotics that are currently used in the feed of the beef and dairy cattle, equine, swine, poultry and aquaculture industries.

This announcement contains forward-looking statements about Vyta Corp that may involve risks and uncertainties. Important factors relating to the Company's operations could cause results to differ materially from those in forward-looking statements and further detailed in filings with the Securities and Exchange Commission (SEC) available at the SEC website ( http://www.sec.gov ). All forward-looking statements are based on information available to Vyta Corp on the date hereof and Vyta Corp assumes no obligation to update such statements.

Contacts:

Vyta Corp

Paul H. Metzinger

President & Chief Executive Officer

370 17th St.

Suite 3640

Denver, CO 80202

303-592-1010

Fax: 303-592-1054

E-mail: paul@vytacorp.com


'/>"/>
SOURCE Vyta Corp
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Affitech Acquires Pharmexas Diabody Technology
2. Millstone Medical Outsourcing Acquires New Facility to Accommodate Growing Business, Provide Additional Clean Room Capacity
3. CPA Acquires Renowned German Patent Research Specialist, SVPG
4. Circassia Acquires North American and Japanese Rights to Dopexamine
5. Advanced Instruments Acquires D & F Control Systems Inc.
6. Milestone Scientific Acquires Additional Patent Rights for Painless Injections and Resolves Related Litigations
7. MediCult Acquires US-Based MidAtlantic Diagnostics to Further Strengthen ART Presence
8. Arisyn Therapeutics Inc. Acquires Highly Novel Portfolio of Therapeutic Small Molecules for Infectious Disease and Cancer
9. Safecor Health Acquires Unit-Dose Pharmaceutical Leader RSC
10. Duff & Phelps Acquires Lumin Expert Group To Build Global Intellectual Property Practice
11. Kowa Company, Ltd. Acquires ProEthic Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... (PRWEB) , ... October 12, ... ... ) has launched Rosalind™, the first-ever genomics analysis platform specifically designed for ... complexity. Named in honor of pioneering researcher Rosalind Franklin, who made a ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ComplianceOnline’s Medical Device ... on 7th and 8th June 2018 in San Francisco, CA. The Summit brings together ... as several distinguished CEOs, board directors and government officials from around the world to ...
(Date:10/11/2017)... ... ... Disappearing forests and increased emissions are the main causes of the evolving air ... living in larger cities are affected by air pollution related diseases. , That is ... globally - decided to take action. , “I knew I had to take action ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
Breaking Biology Technology:
(Date:4/5/2017)... YORK , April 5, 2017 Today ... is announcing that the server component of the HYPR ... known for providing the end-to-end security architecture that empowers ... HYPR has already secured over 15 million ... makers including manufacturers of connected home product suites and ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/30/2017)... Trends, opportunities and forecast in this market ... (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, vein ... use industry (government and law enforcement, commercial and retail, ... others), and by region ( North America ... Pacific , and the Rest of the World) ...
Breaking Biology News(10 mins):